Name: Mendus Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 407 across all filing types

Latest filing 2026-05-08 Regulatory Filings

Country SE Sweden

Listing ST IMMU

About Mendus

https://mendus.com/

Mendus is a clinical-stage company developing immunotherapies to improve long-term survival for cancer patients. The company's primary focus is on preventing tumor recurrence, a leading cause of cancer-related mortality. By leveraging its expertise in allogeneic dendritic cell biology, Mendus designs therapies that stimulate the immune system to build active and long-lasting immunity against residual cancer cells. This approach aims to change the course of cancer treatment by offering durable responses while preserving the patient's quality of life. The company's pipeline is centered on maintenance therapies for various forms of cancer.

Recent filings

Filing	Released	Lang
Report from the Annual General Meeting of Mendus AB (publ) on 8 May 2026 Regulatory Filings	2026-05-08	English
Kommuniké från årsstämma i Mendus AB (publ) den 8 maj 2026 Regulatory Filings	2026-05-08	English
Quarterly Report 2026 Quarterly Report	2026-05-08	English
Quarterly Report 2026 Quarterly Report	2026-05-08	English
Annual Report 2025 Annual Report FY 2025	2026-04-17	Swedish
Notice of Annual General Meeting in Mendus AB (publ) Proxy Solicitation & Information Statement	2026-04-01	English

	ID	Filing	Released	Lang
2026 11 filings
	44140825	Report from the Annual General Meeting of Mendus AB (publ) on 8 May 2026 Regulatory Filings	2026-05-08	English
	44140824	Kommuniké från årsstämma i Mendus AB (publ) den 8 maj 2026 Regulatory Filings	2026-05-08	English
	44106653	Quarterly Report 2026 Quarterly Report	2026-05-08	English
	44106643	Quarterly Report 2026 Quarterly Report	2026-05-08	English
	34652957	Annual Report 2025 Annual Report FY 2025	2026-04-17	Swedish
	33135714	Notice of Annual General Meeting in Mendus AB (publ) Proxy Solicitation & Information Statement	2026-04-01	English
	33135710	Kallelse till årsstämma i Mendus AB (publ) Proxy Solicitation & Information Statement	2026-04-01	Swedish
	19425151	Interim / Quarterly Report 2025 Interim / Quarterly Report Q4 2025	2026-02-11	Swedish
	19425150	Audit Report / Information 2025 Audit Report / Information Q4 2025	2026-02-11	English
	13773646	Mendus draws first tranche of the Fenja Capital II A/S loan facility and resolves on a directed issue of warrants to Fenja Capital/Financing Update	2026-01-30	English
	13773645	Mendus påkallar första tranchen av Fenja Capital II A/S lånefacilitet samt beslutar om riktad emission av teckningsoptioner till Fenja Capital/Financing Update	2026-01-30	Swedish
2025 4 filings
	11467140	Ändring av antalet aktier och röster i Mendus AB (publ) Share Issue/Capital Change	2025-12-30	Swedish
	11467139	Change in number of shares and votes in Mendus AB (publ) Share Issue/Capital Change	2025-12-30	English
	10184538	Kommuniké från extra bolagsstämma i Mendus AB (publ) den 16 december 2025 Declaration of Voting Results & Voting Rights Announcements	2025-12-16	Swedish
	10184537	Report from the Extraordinary General Meeting of Mendus AB (publ) on 16 December 2025 AGM Information	2025-12-16	English

Page 1 of 28

1 2 3 … Next

Financials

We couldn't load the financials

No data available yet

We have extracted financials for Mendus, but not for this combination of statement and period. Try a different combination.

Swipe the table to view all periods, or rotate your phone for a wider view.


Line item

Source filings

Every figure is sourced from a primary regulatory filing. Open any filing to see the original document.

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,117 peers

Company	Ticker	Country	Sector
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. Designs, develops, and manufactures molecular diagnostic so…	ANGEN	TR	Manufacturing
ANAVEX LIFE SCIENCES CORP. Clinical-stage biopharmaceutical company developing therape…	AVXL	US	Manufacturing
Anbio Biotechnology Develops and provides in-vitro diagnostic (IVD) solutions a…	NNNN	KY	Manufacturing
Anebulo Pharmaceuticals, Inc. Clinical-stage biotech developing therapies for acute canna…	ANEB	US	Manufacturing
AnGes, Inc. Biopharmaceutical firm developing gene-based and nucleotide…	4563	JP	Manufacturing
ANG Lifesciences India Limited Develops and manufactures sterile dry powder and liquid inj…	540694	IN	Manufacturing
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. Develops biopharmaceuticals, genetic engineering products, …	300009	CN	Manufacturing
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD Produces injections, solid dosage forms, APIs, and nutritio…	000153	CN	Manufacturing
Anhui Huangshan Capsule Co.,Ltd Produces empty hard capsules, including gelatin and HPMC ve…	002817	CN	Manufacturing
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd Develops and manufactures pharmaceutical excipients for sol…	300452	CN	Manufacturing

Page 14 of 212

Prev … 12 13 14 15 16 … Next

Mendus via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID3163

TickerIMMU

ISINSE0005003654

Endpoints

most-used routes for this company

GET	/api/companies/3163/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=3163	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=3163	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for Mendus

$ curl https://api.financialreports.eu/api/filings/?company=3163 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 3163},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for Mendus (id: 3163)"

Mendus — Investor Relations & Filings